Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study
Tian Yang(Second Military Medical University), Jian‐Hong Zhong(Tumor Hospital of Guangxi Medical University), Wan Yee Lau(Chinese University of Hong Kong), Timothy M. Pawlik(The Ohio State University), Lan‐Qing Yao(Second Military Medical University), Han Wu(Peking University), Xin‐Fei Xu(Second Military Medical University), Wei‐Min Gu(Harbin Medical University), Chao Li(Second Military Medical University), Hong Wang(Liuyang City Maternal and Child Health Hospital), Ya-Hao Zhou(Puer University), Ting‐Hao Chen(National Taiwan University), Feng Shen(Second Military Medical University), Ming-Da Wang(Second Military Medical University)
Cited by 71
Related Papers
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma
|JAMA Surgery|2018|546
Future cancer research priorities in the USA: a Lancet Oncology Commission
|The Lancet Oncology|2017|209
The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph Nodes
|Journal of Clinical Oncology|2005|126